Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an advisor to a number of pharmaceutical and biotechnology companies. He is a founder of Pernix Therapeutics Holdings, Inc, (PTX: NASDAQ), a specialty pharmaceutical company focused on branded, generic, and OTC products. Mr. Collins was a member of the Pernix Board of Directors from 2007 to 2014 and served as President and CEO from 2008 to 2013. Mr. Collins also serves as a Board Member and as Chairman of the Compensation Committee for TherapeuticsMD, Inc, (TXMD:NYSE MKT), a healthcare company focused on developing and commercializing products targeted exclusively for women.